{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:43:08Z","timestamp":1782931388115,"version":"3.54.5"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005683","name":"Kyoto University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Study Objectives<\/jats:title>\n                    <jats:p>To investigate the prescription patterns for hypnotics among patients &amp;lt;18\u00a0years in Japan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a descriptive epidemiologic study using a claims database in Japan. We included patients aged 0\u201317\u00a0years with first-time prescriptions for hypnotics between June 2021 and June 2023. Hypnotics were classified as melatonin, melatonin receptor agonists (MRAs), dual orexin receptor antagonists (DORAs), Z-drugs, and benzodiazepines. We described the types of hypnotics, dosages, prescription duration, comorbidities, and concomitant medications for overall and by age groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 21\u2009145 patients; 1983 aged 0\u20136\u00a0years, 3901 aged 7\u201311\u00a0years, 6664 aged 12\u201314\u00a0years, and 8597 aged 15\u201317\u00a0years. The initial prescribed hypnotics were melatonin (33.9%), MRAs (30.9%), DORAs (18.8%), Z-drugs (10.1%), and benzodiazepines (6.3%). Melatonin was more likely to be prescribed to patients age 0\u201311\u00a0years, MRAs to those aged 0\u201317\u00a0years, and DORAs to patients ages 15\u201317\u00a0years. The most common mental health-related comorbidities were autism spectrum disorder (32.5%), depression (23.4%), attention-deficit hyperactivity disorder (19.8%), and anxiety disorder (18.2%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Melatonin was most frequently prescribed in children for a longer duration than other hypnotics, while MRAs were prescribed across all age groups and DORAs mainly to adolescents. These age-specific patterns suggest that the drug selection was conducted according to patient\u2019s age, since pediatric insomnia might be correlated with psychiatric disorders related to developmental stage. Future research should investigate the long-term effects of hypnotic prescriptions with consideration of comorbid conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/sleep\/zsag067","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:46:32Z","timestamp":1772887592000},"source":"Crossref","is-referenced-by-count":1,"title":["Prescription patterns of hypnotics for children and adolescents in Japan: a descriptive epidemiologic study using a claims database"],"prefix":"10.1093","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0671-5376","authenticated-orcid":false,"given":"Sachiko","family":"Tanaka-Mizuno","sequence":"first","affiliation":[{"name":"Laboratory of Epidemiology and Prevention, Kobe Pharmaceutical University , Kobe ,","place":["Japan"]},{"name":"Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Eisai Co., Ltd. , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1182-1181","authenticated-orcid":false,"given":"Kazuo","family":"Mishima","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Akita University Graduate School of Medicine , Akita ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Sakata","sequence":"additional","affiliation":[{"name":"Eisai Co., Ltd. , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motomu","family":"Suga","sequence":"additional","affiliation":[{"name":"Graduate School of Clinical Psychology, Teikyo Heisei University , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ohashi","sequence":"additional","affiliation":[{"name":"National Hospital Organization Mie National Hospital , Mie ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kubota","sequence":"additional","affiliation":[{"name":"Eisai Co., Ltd. , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Koebis","sequence":"additional","affiliation":[{"name":"Eisai Co., Ltd. , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-0737","authenticated-orcid":false,"given":"Toshiki","family":"Fukasawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University , Kyoto ,","place":["Japan"]},{"name":"Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University , Kyoto ,","place":["Japan"]},{"name":"Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Ishii","sequence":"additional","affiliation":[{"name":"Eisai Co., Ltd. , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Moline","sequence":"additional","affiliation":[{"name":"Eisai Inc. , NJ ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-4071","authenticated-orcid":false,"given":"Koji","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"2026061506413060300_ref1","doi-asserted-by":"publisher","first-page":"1332723","DOI":"10.3389\/fped.2024.1332723","article-title":"Prevalence and factors of sleep problems among Japanese children: a population-based study","volume":"12","author":"Kuki","year":"2024","journal-title":"Front Pediatr"},{"key":"2026061506413060300_ref2","doi-asserted-by":"publisher","first-page":"100107","DOI":"10.1016\/j.lanwpc.2021.100107","article-title":"Trends in sleep problems and patterns among Japanese adolescents: 2004 to 2017","volume":"9","author":"Otsuka","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"issue":"12","key":"2026061506413060300_ref3","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/sleep\/29.12.1543","article-title":"Insomnia among Japanese adolescents: a nationwide representative survey","volume":"29","author":"Kaneita","year":"2006","journal-title":"Sleep."},{"issue":"5","key":"2026061506413060300_ref4","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00787-023-02253-1","article-title":"Correlations between sleep problems, core symptoms, and behavioral problems in children and adolescents with autism spectrum disorder: a systematic review and meta-analysis","volume":"33","author":"Kim","year":"2024","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"3","key":"2026061506413060300_ref5","doi-asserted-by":"publisher","first-page":"e20180492","DOI":"10.1542\/peds.2018-0492","article-title":"Sleep problems in 2- to 5-year-olds with autism spectrum disorder and other developmental delays","volume":"143","author":"Reynolds","year":"2019","journal-title":"Pediatrics."},{"key":"2026061506413060300_ref6","doi-asserted-by":"publisher","first-page":"101533","DOI":"10.1016\/j.lanwpc.2025.101533","article-title":"Twelve-month prevalence of DSM-5 mental disorders and the psychosocial correlates- a child and adolescent psychiatric epidemiologic survey in Hong Kong SAR","volume":"57","author":"Chan","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"2026061506413060300_ref7","doi-asserted-by":"publisher","first-page":"27921","DOI":"10.1038\/srep27921","article-title":"Insomnia, health-related quality of life and health outcomes in children: a seven year longitudinal cohort","volume":"6","author":"Combs","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"2026061506413060300_ref8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"9","key":"2026061506413060300_ref9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1212\/WNL.0000000000009033","article-title":"Practice guideline: treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"94","author":"Williams Buckley","year":"2020","journal-title":"Neurology."},{"issue":"7","key":"2026061506413060300_ref10","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1007\/s00431-024-05556-w","article-title":"European expert guidance on management of sleep onset insomnia and melatonin use in typically developing children","volume":"183","author":"Bruni","year":"2024","journal-title":"Eur J Pediatr"},{"issue":"2","key":"2026061506413060300_ref11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamapsychiatry.2022.4165","article-title":"Psychotropic medication use and psychiatric disorders during the COVID-19 pandemic among Danish children, adolescents, and young adults","volume":"80","author":"Bliddal","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"2026061506413060300_ref12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1212\/01.CPJ.0000442521.30233.ef","article-title":"Medications for sleep disturbances in children","volume":"4","author":"Felt","year":"2014","journal-title":"Neurol Clin Pract"},{"key":"2026061506413060300_ref13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.sleep.2021.01.028","article-title":"Melatonin dispensing among New Zealand children aged 0-18 years with autism: a nationwide cross-sectional study","volume":"80","author":"McLay","year":"2021","journal-title":"Sleep Med"},{"issue":"4","key":"2026061506413060300_ref14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s12519-016-0036-8","article-title":"Prescription trends in children with pervasive developmental disorders: a claims data-based study in Japan","volume":"12","author":"Satoh","year":"2016","journal-title":"World J Pediatr"},{"issue":"1","key":"2026061506413060300_ref15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12888-023-04683-2","article-title":"Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database","volume":"23","author":"Okuda","year":"2023","journal-title":"BMC Psychiatry"},{"issue":"12","key":"2026061506413060300_ref16","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/14656566.2024.2392018","article-title":"Evaluation of prescribing patterns of switching to and add-on lemborexant in patients treated with hypnotic medication: a nationwide claims database study in Japan","volume":"25","author":"Tanaka-Mizuno","year":"2024","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"2026061506413060300_ref17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/pcn.13525","article-title":"Effects of Japanese policies and novel hypnotics on long-term prescriptions of hypnotics","volume":"77","author":"Takeshima","year":"2023","journal-title":"Psychiatry Clin Neurosci"},{"issue":"3","key":"2026061506413060300_ref18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/jgf2.422","article-title":"Data resource profile: JMDC claims database sourced from health insurance societies","volume":"22","author":"Nagai","year":"2021","journal-title":"J Gen Fam Med"},{"issue":"10","key":"2026061506413060300_ref19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2183\/pjab.98.026","article-title":"Clinical epidemiology and pharmacoepidemiology studies with real-world databases","volume":"98","author":"Yoshida","year":"2022","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"1","key":"2026061506413060300_ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40748-018-0096-y","article-title":"Association between antidepressant use during pregnancy and autism spectrum disorder in children: a retrospective cohort study based on Japanese claims data","volume":"5","author":"Yamamoto-Sasaki","year":"2019","journal-title":"Matern Health Neonatol Perinatol"},{"issue":"1","key":"2026061506413060300_ref21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.psc.2023.06.006","article-title":"Medications used for pediatric insomnia","volume":"47","author":"Ekambaram","year":"2024","journal-title":"Psychiatr Clin North Am"},{"issue":"5","key":"2026061506413060300_ref22","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsae057","article-title":"Psychiatric comorbidities and prescribing tendencies of sleep medications and related medications in young people with insomnia: a United States commercial claims-based analysis","volume":"47","author":"Bushnell","year":"2024","journal-title":"Sleep."},{"key":"2026061506413060300_ref23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.sleep.2025.01.004","article-title":"Trends in anti-insomnia medication utilization among pediatric patients in nine cities in China: a real-world study (2016-2023)","volume":"127","author":"Li","year":"2025","journal-title":"Sleep Med"},{"issue":"8","key":"2026061506413060300_ref24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatry Clin Neurosci"},{"issue":"9","key":"2026061506413060300_ref25","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00787-020-01598-1","article-title":"Pediatric use of prescribed melatonin in Sweden 2006-2017: a register based study","volume":"30","author":"Kimland","year":"2021","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"10","key":"2026061506413060300_ref26","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s00787-022-02035-1","article-title":"Melatonin use among children, adolescents, and young adults: a Danish nationwide drug utilization study","volume":"32","author":"Bliddal","year":"2023","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"2","key":"2026061506413060300_ref27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5664\/jcsm.27443","article-title":"The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome","volume":"5","author":"Wirojanan","year":"2009","journal-title":"J Clin Sleep Med"},{"key":"2026061506413060300_ref28","doi-asserted-by":"publisher","first-page":"e6664","DOI":"10.1136\/bmj.e6664","article-title":"Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial","volume":"345","author":"Gringras","year":"2012","journal-title":"BMJ."},{"key":"2026061506413060300_ref29","doi-asserted-by":"publisher","first-page":"1168100","DOI":"10.3389\/fpsyt.2023.1168100","article-title":"Treatment strategy for insomnia disorder: Japanese expert consensus","volume":"14","author":"Takaesu","year":"2023","journal-title":"Front Psychiatry"},{"issue":"2","key":"2026061506413060300_ref30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaac.2019.12.007","article-title":"Sleep, growth, and puberty after 2 years of prolonged-release melatonin in children with autism spectrum disorder","volume":"60","author":"Malow","year":"2021","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"16","key":"2026061506413060300_ref31","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1111\/bph.14116","article-title":"New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation","volume":"175","author":"Zisapel","year":"2018","journal-title":"Br J Pharmacol"},{"key":"2026061506413060300_ref32","doi-asserted-by":"publisher","first-page":"1280131","DOI":"10.3389\/fneur.2023.1280131","article-title":"The optimal dose of ramelteon for the better treatment adherence of delayed sleep-wake phase disorder: a dropout rate study","volume":"14","author":"Takagi","year":"2023","journal-title":"Front Neurol"},{"key":"2026061506413060300_ref33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jad.2015.05.002","article-title":"Recent trends in the incidence of anxiety and prescription of anxiolytics and hypnotics in children and young people: an e-cohort study","volume":"183","author":"John","year":"2015","journal-title":"J Affect Disord"},{"issue":"9820","key":"2026061506413060300_ref34","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S0140-6736(11)60871-4","article-title":"Depression in adolescence","volume":"379","author":"Thapar","year":"2012","journal-title":"Lancet."},{"issue":"5","key":"2026061506413060300_ref35","doi-asserted-by":"publisher","first-page":"e190025","DOI":"10.1001\/jamapediatrics.2019.0025","article-title":"Association of atopic dermatitis with sleep quality in children","volume":"173","author":"Ramirez","year":"2019","journal-title":"JAMA Pediatr"},{"key":"2026061506413060300_ref36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.genhosppsych.2019.11.008","article-title":"Long-term use of hypnotics: analysis of trends and risk factors","volume":"62","author":"Enomoto","year":"2020","journal-title":"Gen Hosp Psychiatry"}],"container-title":["SLEEP"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/sleep\/advance-article-pdf\/doi\/10.1093\/sleep\/zsag067\/67279372\/zsag067.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/49\/6\/zsag067\/67279372\/zsag067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/49\/6\/zsag067\/67279372\/zsag067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:41:38Z","timestamp":1781520098000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sleep\/article\/doi\/10.1093\/sleep\/zsag067\/8512079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3,9]]},"published-print":{"date-parts":[[2026,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/sleep\/zsag067","relation":{},"ISSN":["0161-8105","1550-9109"],"issn-type":[{"value":"0161-8105","type":"print"},{"value":"1550-9109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,3,9]]},"article-number":"zsag067"}}